Revance Therapeutics Inc (FRA:RTI)
€ 3.4 -0.1 (-2.86%) Market Cap: 371.12 Mil Enterprise Value: 655.05 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 68/100

Revance Therapeutics Inc at Wells Fargo Virtual Healthcare Conference Transcript

Sep 09, 2021 / 04:40PM GMT
Release Date Price: €23.8 (+3.48%)
Jessica Serra
Revance Therapeutics, Inc. - Head of IR & ESG

Welcome to the Wells Fargo Bank and Tech Pop-up Virtual Conference. Before we get started, if you are a member of the press or media, please disconnect at this time. This is a restricted line. Any unauthorized party in this meeting or any unauthorized use of the information communicated in this meeting is subject to prosecution to the fullest extent of the law. Any unauthorized person, including the media that is on the line at this time, please disconnect. Please note, today's call is being recorded.

Jacob William Hughes
Wells Fargo Securities, LLC, Research Division - Senior Analyst

Great. Thanks, everyone, for joining us. We're continuing day 1 of 2021 Wells Fargo Healthcare Conference. I'm Jacob Hughes, Specialty Pharmaceuticals Analyst at Wells Fargo. Next up, I'm very excited to have Revance Therapeutics. From the company, I'm pleased to introduce President and CEO, Mark Foley; CFO, Toby Schilke; and Jessica Serra from IR. (Operator Instructions) Alternatively, you can e-mail me directly at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot